Financial Shenanigans

Financial Shenanigans

Yadea earns a Forensic Risk Score of 48 (Elevated). The numbers are not obviously distorted, but three forensic signals fire at once on the FY2025 result: an unexplained Big-Four auditor swap (PwC out, Deloitte in) eight months before the FY2025 audit closed, the introduction of a new supplier-finance programme that already routed ¥1.48B of bills through banks while keeping the cash settlements inside operating cash flow, and an operating cash flow that swung from ¥299M to ¥5,990M almost entirely on a ¥2.3B build in bills payable. None of this is fraud — it is aggressive working-capital and presentation management in a +129% rebound year under tight founder control. The single data point that would most de-risk the grade is the FY2026 interim cash flow: if CFO/NI stays above 1.0× without further bills-payable expansion, most of the elevated risk converts to "watch."

The Forensic Verdict

Shenanigans scorecard — 13 categories

The scorecard gives three reds (supplier finance, working-capital CFO, plus breeding-ground via the auditor swap covered in §2), six yellows, and five clean negatives. The reds cluster around cash-flow presentation, not revenue or earnings — Yadea's income statement is broadly defensible, but the cash-flow statement is doing more presentational work than the surface 2.06× CFO/NI suggests.

Breeding Ground

The governance environment dampens external challenge to aggressive choices. Yadea is founder-controlled, family-managed, and the audit relationship was reset mid-rebound.

The PwC-to-Deloitte rotation is the single signal a forensic reader cannot wave away. PwC accepted reappointment on 17 June 2025, walked away 56 days later, and Deloitte stepped into the casual vacancy in September. Yadea's published rationale is generic ("current business situation and future needs of audit services") and neither auditor has flagged a disagreement. In a vacuum that wording is HKEX-standard boilerplate; in the context of a +129% profit rebound, a brand-new supplier-finance programme, and a ¥2.3B bills-payable build, the timing is conspicuous. The compounding signal is the audit fee falling 11% year-on-year against a balance sheet that grew 22% — auditor-change years usually carry a fee bump, not a cut. Wong Lung Ming's announced 2026 resignation makes this three governance changes in eighteen months.

The breeding ground does not prove anything. It does tell you that internal checks on aggressive accounting choices are concentrated in one Audit-Committee chair (Mr. Chen Mingyu) and a newly appointed auditor.

Earnings Quality

The income statement is more defensible than the cash-flow statement. Receivables grew far slower than revenue, no reserves were obviously raided, and the auditor's only Key Audit Matter was a standard revenue cut-off review that passed. The earnings-quality concerns are second-order: a meaningful share of operating profit comes from wealth-management gains and government grants, and reserves drift in the helpful direction.

Trade receivables are flat at ¥470M against ¥37B of revenue — a DSO of 4.6 days that reflects the distributor-prepayment model rather than any accounting choice. The auditor confirmed cut-off testing and distributor existence as part of the FY2025 audit. This is a clean test for the revenue line. What is less clean: contract liabilities (advance from distributors) fell 23% to ¥318M while revenue grew 31% — distributor confidence in the pipeline did not scale with the print. The shrinkage is consistent with either tighter channel-financing terms or weaker forward orders.

Operating profit of ¥3,639M includes ¥710M of "other income and gains" — 19.5% of operating profit. Of that, ¥229M is government grants, ¥173M is VAT super-deduction, and ¥180M is fair-value gains on ¥4,766M of bank-issued wealth-management products and structured deposits. These items are real, recurring under current PRC policy, and disclosed — but stripping them brings operating margin from 9.83% to ~7.9%, and the FY25 print loses ~¥580M of "operational" feel. Yadea labels none of these as non-recurring, which is the correct treatment but worth a flag for anyone modelling normalised earnings.

Reserves drift the way a manager who wanted to flatter earnings would want them to drift: receivable allowances and warranty liabilities are released, the rebate accrual builds in line with sales. None of the moves are large enough to swing the headline meaningfully — combined warranty release adds ~¥42M to pre-tax profit, less than 1.2% of profit before tax — but the pattern is one-directional.

Cash Flow Quality

This is where the forensic reader should focus. Reported FY2025 CFO is ¥5,989.8M against ¥298.9M in FY2024 — a 20× swing. That headline overstates the operational improvement.

CFO/NI = 2.06× in FY2025 and 0.23× in FY2024. The two-year average of 1.50× still sounds healthy, but decomposition shows where it came from:

The single largest contributor is Δ trade and bills payables = +¥2,298M, more than 38% of cash generated from operations. Drilling into the note: trade-payables (the genuine arms-length item) rose only ¥616M, from ¥3,631M to ¥4,247M. The other ¥1,612M of the build is in bills payable, which rose from ¥8,241M to ¥9,852M — bank-guaranteed promissory notes secured by ¥4,360M of pledged bank deposits. These are functionally a form of short-term bank financing dressed as supplier credit.

A new disclosure in FY2025 makes the picture sharper. Note 29 reveals that Yadea has, in 2025 only, entered into a supplier-finance arrangement: certain suppliers can discount Yadea-issued bills at banks, with Yadea paying the discount interest. Total bills discounted in 2025: ¥1,476.5M (FY24: nil). Outstanding at year-end: ¥1,079M. Settlements stay inside CFO. This is a textbook supplier-finance / reverse-factoring programme — disclosure is in line with HKFRS but the cash-flow classification means working-capital improvements that are actually bank-funded show up as operating strength.

After stripping the bills-payable build and the supplier-finance programme, adjusted CFO is ~¥3.3B and CFO/NI falls to 1.13× — still positive, but the "lifeline" view replaces the "cash-generative compounder" view. FCF after maintenance capex remains positive at ~¥2.5B, so this is not a cash-burning business; it is a business whose headline CFO is amplified by bank-mediated working-capital management.

The FY2024 picture is the inverse and equally instructive. Bills payable fell ¥1.76B that year, working capital absorbed cash, and the company's defence at the time was that tax-paid of ¥424M was the swing item. The honest read is that Yadea's CFO is a working-capital story driven by the bills-payable ledger more than by underlying operations, in both directions.

Metric Hygiene

Yadea's reported headline metrics reconcile directly to the financial statements — there is no adjusted-EBITDA culture and no "cash earnings" framing. The hygiene concerns are subtler.

The two hygiene items that meaningfully change the picture are the gearing ratio (which excludes ¥9.85B of bank-backed bills payable while including ¥1.46B of explicit borrowings) and the net-current-assets narrative. Management explains the FY25 net current liability of ¥1.88B as a deliberate decision to reclassify ¥4,587M of deposits to non-current to capture higher interest rates. That is plausible treasury management — and it conveniently moves cash off the current-assets line so the working-capital tightness from the bills-payable book is mathematically offset by a non-current asset that the reader has to seek out in Notes 24 and 25.

What to Underwrite Next

Five forensic monitors should sit on the next-quarter checklist.